Hemostasis & Tissue Sealing Agents Market

Hemostasis & Tissue Sealing Agents Market - Global
Industry Insights and Forecast to 2025
Hemostasis is a physiological processes, which maintains fluidity of blood by preventing blood
loss from body. Hemostasis is characterized by clot formation by activating the natural
coagulation cascade. However, in cases of major surgeries and trauma, the blood loss is
excessive and cannot be stopped through natural healing process. Thus, hemostats and tissue
sealing agents aid in such situations by minimizing the blood loss and helps in healing the
injury. Hemostats and tissue sealing agents are increasingly being used, as excessive bleeding
during surgical procedures can lead to high risk. Moreover, excessive bleeding can also result in
postoperative complications that include prolonged surgical procedures and insufficient blood in
the body. According to In-Patient Epidemiology, a statistical survey conducted by Department of
Surgery, Division of Acute Care and Trauma Surgery, New York University 2012, blood loss
accounts for up to 31% of deaths in victims of trauma and catastrophic accident patients in the
U.S. Therefore, prevention of such occurrences is important for positive patient outcomes and
success of surgical procedures. Thus, topical hemostats in terms of mechanical hemostats, active
hemostats, and Flowable hemostats, that are solutions topically applied directly on the bleeding
site as well as natural and synthetic tissue sealants act as adjunct to natural hemostasis
procedure and are applied locally to control blood loss.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/1567
Rising number of surgical procedures coupled with increasing trauma cases to foster global
hemostasis & tissue sealing agents market
Factors such as increasing number of surgical procedures as well as rising number of road
accidents are expected to significantly contribute to growth of the hemostasis and tissue sealing
agents market. For instance, according to Health and Social Care Information Centre (HSCIC),
surgery is one of the most important treatments offered by NHS care in the U.K., and
accounted for 4.7 million admissions across multiple sectors in 2013-14. The data also suggests
that the number of surgical procedures has increased by 27% between 2004 and 2014.
According to Centers of Disease Control and Prevention (CDC), around 200,000 deaths were
encountered in 2014, due to trauma injuries in the U.S. Increasing incidence of road accidents
has led to traumatic sport injuries is a major factor fueling demand for hemostats, thereby
driving the market growth. According to the World Health Organization 2016, over 50%
affected in road traffic accidents were admitted in the hospitals and underwent trauma
surgeries. Hemostats are used in trauma surgeries and also in various conventional surgeries
such as hernia repair surgery, orthopedic, open heart and cardiovascular surgeries, and
neurosurgery that involve significant blood loss, due to larger size incisions made on the body
of the patient. According to the annual report of American Joint Replacement Registry (AJRR),
2016, a total of 427,181 procedures were reported for joint replacement surgeries. However,
lack of favorable reimbursement policies for failure of hemostats in blood loss control as well as
increasing cost of surgical procedures is expected to hinder the market growth.
Report includes chapters which deeply display the following deliverable about industry :
• Hemostasis & Tissue Sealing Agents Market Research Objective and Assumption
• Hemostasis & Tissue Sealing Agents Market Purview - Report Description, Executive Summary,
and Coherent Opportunity Map (COM)
• Hemostasis & Tissue Sealing Agents Market Dynamics, Regulations, and Trends Analysis Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Hemostasis & Tissue Sealing Agents Market, By Regions
• Hemostasis & Tissue Sealing Agents Market Competition by Manufacturers including
Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and
Product Type.
• Hemostasis & Tissue Sealing Agents Market Manufacturers Profiles/Analysis including Company
Basic Information, Manufacturing Base and Its Competitors.
• Hemostasis & Tissue Sealing Agents Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Hemostasis & Tissue Sealing Agents Market Forecast including Production, Consumption,
Import and Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Market Dynamics
Hemostats and tissue sealants are used in a wide range of medical applications that include
hernia fixation surgery, orthopedic surgery, spinal injury, trauma or accident wound closure,
ophthalmic injuries or replacements, burns, neurosurgeries, urological disorders, and other
chronic conditions to control excessive bleeding. Thus, increasing number of surgical procedures
is expected to be a major factor augmenting growth of the global hemostasis and tissue sealing
agents market. For instance, according to the Wound Management Innovation Center, 2015,
wounds are estimated to affect over 433,000 people in Australia and the economic burden is
estimated to be around US$ 2.85 billion per year. Moreover, according to The World Bank in
2012, the number of surgical procedures performed per 100,000 population were accounted to
be 4,511 globally. However, lack of reimbursement for these agents and products could hinder
the market growth.
Ask For Discount Before Purchasing This Business Report @
https://www.coherentmarketinsights.com/insight/request-discount/1567
Key players operating the global hemostasis & tissue sealing agents market include Cryolife, Inc.
Baxter International, Inc., Ethicon LLC, Integra Lifesciences Corporation, Becton, Dickinson &
Company, Cohera Medical, Inc., Pfizer, Inc., Medtronic plc, B. Braun Melsungen AG, MIL
Laboratories Pvt. Ltd, Advanced Medical Solutions Group Plc, and others.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Hemostasis is a physiological processes, which maintains fluidity of blood by preventing blood loss from body.

Download Report